CA2281335A1 - Methode et dispositif pour renforcer et accroitre les elements vertebraux - Google Patents

Methode et dispositif pour renforcer et accroitre les elements vertebraux Download PDF

Info

Publication number: CA2281335A1
Authority: CA; Canada
Prior art keywords: cement; patients; vertebroplasty; vertebral; percutaneous
Prior art date: 1999-09-02
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002281335A

Other languages

English (en)

Inventor

Kieran Murphy

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-02

Filing date

1999-09-02

Publication date

2001-03-02

1999-09-02 Application filed by Individual filed Critical Individual

1999-09-02 Priority to CA002281335A priority Critical patent/CA2281335A1/fr

1999-10-22 Priority to US09/425,480 priority patent/US6273916B1/en

1999-10-22 Priority to CA002287112A priority patent/CA2287112C/fr

2000-06-16 Priority to US09/594,685 priority patent/US7563265B1/en

2001-03-02 Publication of CA2281335A1 publication Critical patent/CA2281335A1/fr

Status Abandoned legal-status Critical Current

Links

238000000034 method Methods 0.000 title description 46
238000005728 strengthening Methods 0.000 title description 2
230000003190 augmentative effect Effects 0.000 title 1
239000004568 cement Substances 0.000 description 53
208000002193 Pain Diseases 0.000 description 32
238000002347 injection Methods 0.000 description 32
239000007924 injection Substances 0.000 description 32
230000036407 pain Effects 0.000 description 28
VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 18
238000011282 treatment Methods 0.000 description 15
206010027476 Metastases Diseases 0.000 description 13
238000011049 filling Methods 0.000 description 12
230000003902 lesion Effects 0.000 description 11
238000001356 surgical procedure Methods 0.000 description 11
201000011066 hemangioma Diseases 0.000 description 10
206010017076 Fracture Diseases 0.000 description 9
238000013459 approach Methods 0.000 description 9
229910052788 barium Inorganic materials 0.000 description 9
DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 9
239000000178 monomer Substances 0.000 description 9
230000001009 osteoporotic effect Effects 0.000 description 9
229920003229 poly(methyl methacrylate) Polymers 0.000 description 8
239000004926 polymethyl methacrylate Substances 0.000 description 8
206010035226 Plasma cell myeloma Diseases 0.000 description 7
210000000988 bone and bone Anatomy 0.000 description 7
239000002639 bone cement Substances 0.000 description 7
238000002594 fluoroscopy Methods 0.000 description 7
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
238000002690 local anesthesia Methods 0.000 description 6
206010061289 metastatic neoplasm Diseases 0.000 description 6
206010028980 Neoplasm Diseases 0.000 description 5
208000001132 Osteoporosis Diseases 0.000 description 5
208000010378 Pulmonary Embolism Diseases 0.000 description 5
230000003416 augmentation Effects 0.000 description 5
230000006872 improvement Effects 0.000 description 5
230000000010 osteolytic effect Effects 0.000 description 5
206010041569 spinal fracture Diseases 0.000 description 5
210000000115 thoracic cavity Anatomy 0.000 description 5
210000003462 vein Anatomy 0.000 description 5
208000010392 Bone Fractures Diseases 0.000 description 4
206010041541 Spinal compression fracture Diseases 0.000 description 4
239000003522 acrylic cement Substances 0.000 description 4
UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 4
230000006835 compression Effects 0.000 description 4
238000007906 compression Methods 0.000 description 4
230000000991 decompressive effect Effects 0.000 description 4
239000007788 liquid Substances 0.000 description 4
238000002156 mixing Methods 0.000 description 4
201000000050 myeloid neoplasm Diseases 0.000 description 4
238000001959 radiotherapy Methods 0.000 description 4
230000006641 stabilisation Effects 0.000 description 4
238000011105 stabilization Methods 0.000 description 4
238000012800 visualization Methods 0.000 description 4
206010010214 Compression fracture Diseases 0.000 description 3
229920001651 Cyanoacrylate Polymers 0.000 description 3
NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 3
208000034578 Multiple myelomas Diseases 0.000 description 3
206010041549 Spinal cord compression Diseases 0.000 description 3
230000001054 cortical effect Effects 0.000 description 3
230000009089 cytolysis Effects 0.000 description 3
201000010099 disease Diseases 0.000 description 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
JJJFUHOGVZWXNQ-UHFFFAOYSA-N enbucrilate Chemical compound CCCCOC(=O)C(=C)C#N JJJFUHOGVZWXNQ-UHFFFAOYSA-N 0.000 description 3
229950010048 enbucrilate Drugs 0.000 description 3
238000003384 imaging method Methods 0.000 description 3
238000002684 laminectomy Methods 0.000 description 3
229960004194 lidocaine Drugs 0.000 description 3
230000003211 malignant effect Effects 0.000 description 3
239000000463 material Substances 0.000 description 3
230000001394 metastastic effect Effects 0.000 description 3
239000000203 mixture Substances 0.000 description 3
230000000399 orthopedic effect Effects 0.000 description 3
239000000843 powder Substances 0.000 description 3
206010002091 Anaesthesia Diseases 0.000 description 2
208000008035 Back Pain Diseases 0.000 description 2
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
206010027468 Metastases to spine Diseases 0.000 description 2
208000001164 Osteoporotic Fractures Diseases 0.000 description 2
206010037779 Radiculopathy Diseases 0.000 description 2
208000020307 Spinal disease Diseases 0.000 description 2
208000005298 acute pain Diseases 0.000 description 2
238000001949 anaesthesia Methods 0.000 description 2
230000037005 anaesthesia Effects 0.000 description 2
230000036592 analgesia Effects 0.000 description 2
230000009286 beneficial effect Effects 0.000 description 2
238000002512 chemotherapy Methods 0.000 description 2
238000011443 conventional therapy Methods 0.000 description 2
230000002596 correlated effect Effects 0.000 description 2
230000006378 damage Effects 0.000 description 2
238000013461 design Methods 0.000 description 2
238000011161 development Methods 0.000 description 2
230000018109 developmental process Effects 0.000 description 2
239000003814 drug Substances 0.000 description 2
229940079593 drug Drugs 0.000 description 2
230000000694 effects Effects 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
229910052500 inorganic mineral Inorganic materials 0.000 description 2
230000007774 longterm Effects 0.000 description 2
230000002101 lytic effect Effects 0.000 description 2
238000002483 medication Methods 0.000 description 2
230000009401 metastasis Effects 0.000 description 2
239000011707 mineral Substances 0.000 description 2
230000001537 neural effect Effects 0.000 description 2
210000004872 soft tissue Anatomy 0.000 description 2
230000000392 somatic effect Effects 0.000 description 2
210000000278 spinal cord Anatomy 0.000 description 2
230000002459 sustained effect Effects 0.000 description 2
229910052715 tantalum Inorganic materials 0.000 description 2
GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
230000001052 transient effect Effects 0.000 description 2
241000153246 Anteros Species 0.000 description 1
206010065687 Bone loss Diseases 0.000 description 1
101100421200 Caenorhabditis elegans sep-1 gene Proteins 0.000 description 1
208000000094 Chronic Pain Diseases 0.000 description 1
206010050702 Crush syndrome Diseases 0.000 description 1
206010011985 Decubitus ulcer Diseases 0.000 description 1
206010051055 Deep vein thrombosis Diseases 0.000 description 1
206010015866 Extravasation Diseases 0.000 description 1
208000032843 Hemorrhage Diseases 0.000 description 1
206010027452 Metastases to bone Diseases 0.000 description 1
206010029174 Nerve compression Diseases 0.000 description 1
208000031264 Nerve root compression Diseases 0.000 description 1
241000772600 Norion Species 0.000 description 1
208000003076 Osteolysis Diseases 0.000 description 1
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
206010033892 Paraplegia Diseases 0.000 description 1
208000031481 Pathologic Constriction Diseases 0.000 description 1
208000006735 Periostitis Diseases 0.000 description 1
206010035664 Pneumonia Diseases 0.000 description 1
241001296096 Probles Species 0.000 description 1
208000006193 Pulmonary infarction Diseases 0.000 description 1
206010059604 Radicular pain Diseases 0.000 description 1
208000027790 Rib fracture Diseases 0.000 description 1
241000219289 Silene Species 0.000 description 1
206010047249 Venous thrombosis Diseases 0.000 description 1
QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
230000000202 analgesic effect Effects 0.000 description 1
238000002583 angiography Methods 0.000 description 1
230000003110 anti-inflammatory effect Effects 0.000 description 1
239000003146 anticoagulant agent Substances 0.000 description 1
229940127219 anticoagulant drug Drugs 0.000 description 1
230000010108 arterial embolization Effects 0.000 description 1
230000000975 bioactive effect Effects 0.000 description 1
239000012620 biological material Substances 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
230000008468 bone growth Effects 0.000 description 1
229910000019 calcium carbonate Inorganic materials 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
210000000038 chest Anatomy 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
238000002591 computed tomography Methods 0.000 description 1
230000034994 death Effects 0.000 description 1
230000006837 decompression Effects 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000006735 deficit Effects 0.000 description 1
230000003111 delayed effect Effects 0.000 description 1
239000000645 desinfectant Substances 0.000 description 1
230000001066 destructive effect Effects 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
230000036251 extravasation Effects 0.000 description 1
238000001125 extrusion Methods 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
208000004967 femoral neuropathy Diseases 0.000 description 1
239000000835 fiber Substances 0.000 description 1
239000012634 fragment Substances 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
230000023597 hemostasis Effects 0.000 description 1
201000008298 histiocytosis Diseases 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
238000002697 interventional radiology Methods 0.000 description 1
210000003127 knee Anatomy 0.000 description 1
210000002664 langerhans' cell Anatomy 0.000 description 1
210000004705 lumbosacral region Anatomy 0.000 description 1
208000029791 lytic metastatic bone lesion Diseases 0.000 description 1
238000013508 migration Methods 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000002324 minimally invasive surgery Methods 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
239000004081 narcotic agent Substances 0.000 description 1
210000005036 nerve Anatomy 0.000 description 1
210000001640 nerve ending Anatomy 0.000 description 1
238000002610 neuroimaging Methods 0.000 description 1
230000007971 neurological deficit Effects 0.000 description 1
230000000926 neurological effect Effects 0.000 description 1
239000002674 ointment Substances 0.000 description 1
239000003605 opacifier Substances 0.000 description 1
229940127240 opiate Drugs 0.000 description 1
230000001151 other effect Effects 0.000 description 1
230000001575 pathological effect Effects 0.000 description 1
210000003460 periosteum Anatomy 0.000 description 1
230000002085 persistent effect Effects 0.000 description 1
238000000554 physical therapy Methods 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
238000009101 premedication Methods 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
238000004321 preservation Methods 0.000 description 1
230000008569 process Effects 0.000 description 1
210000001147 pulmonary artery Anatomy 0.000 description 1
230000007575 pulmonary infarction Effects 0.000 description 1
238000002601 radiography Methods 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000000306 recurrent effect Effects 0.000 description 1
230000002787 reinforcement Effects 0.000 description 1
230000003014 reinforcing effect Effects 0.000 description 1
238000002271 resection Methods 0.000 description 1
238000012552 review Methods 0.000 description 1
210000003625 skull Anatomy 0.000 description 1
208000037959 spinal tumor Diseases 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
230000036262 stenosis Effects 0.000 description 1
208000037804 stenosis Diseases 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
239000000126 substance Substances 0.000 description 1
230000009747 swallowing Effects 0.000 description 1
238000002636 symptomatic treatment Methods 0.000 description 1
238000012549 training Methods 0.000 description 1
WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
229910052721 tungsten Inorganic materials 0.000 description 1
239000010937 tungsten Substances 0.000 description 1
238000010626 work up procedure Methods 0.000 description 1
229910052726 zirconium Inorganic materials 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/0047—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L24/0073—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix
- A61L24/0089—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material with a macromolecular matrix containing inorganic fillers not covered by groups A61L24/0078 or A61L24/0084
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/58—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor for osteosynthesis, e.g. bone plates, screws or setting implements
- A61B17/88—Osteosynthesis instruments; Methods or means for implanting or extracting internal or external fixation devices
- A61B17/8802—Equipment for handling bone cement or other fluid fillers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B2017/564—Methods for bone or joint treatment
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/38—Materials or treatment for tissue regeneration for reconstruction of the spine, vertebrae or intervertebral discs

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Materials Engineering (AREA)
Surgery (AREA)
Inorganic Chemistry (AREA)
Composite Materials (AREA)
Dermatology (AREA)
Medicinal Chemistry (AREA)
Oral & Maxillofacial Surgery (AREA)
Transplantation (AREA)
Materials For Medical Uses (AREA)

CA002281335A 1999-09-02 1999-09-02 Methode et dispositif pour renforcer et accroitre les elements vertebraux Abandoned CA2281335A1 (fr)

Priority Applications (4)

Application Number	Priority Date	Filing Date	Title
CA002281335A CA2281335A1 (fr)	1999-09-02	1999-09-02	Methode et dispositif pour renforcer et accroitre les elements vertebraux
US09/425,480 US6273916B1 (en)	1999-09-02	1999-10-22	Method and apparatus for strengthening vertebral bodies
CA002287112A CA2287112C (fr)	1999-09-02	1999-10-22	Methode et appareil pour renforcer les corps vertebraux
US09/594,685 US7563265B1 (en)	1999-09-02	2000-06-16	Apparatus for strengthening vertebral bodies

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA002281335A CA2281335A1 (fr)	1999-09-02	1999-09-02	Methode et dispositif pour renforcer et accroitre les elements vertebraux

Publications (1)

Publication Number	Publication Date
CA2281335A1 true CA2281335A1 (fr)	2001-03-02

Family

ID=4164071

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002281335A Abandoned CA2281335A1 (fr)	1999-09-02	1999-09-02	Methode et dispositif pour renforcer et accroitre les elements vertebraux

Country Status (1)

Country	Link
CA (1)	CA2281335A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN109549815A (zh) *	2017-09-24	2019-04-02	湖北职业技术学院	一种娱乐健身康复车颈椎腰椎被动和主动康复训练装置

1999
- 1999-09-02 CA CA002281335A patent/CA2281335A1/fr not_active Abandoned

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN109549815A (zh) *	2017-09-24	2019-04-02	湖北职业技术学院	一种娱乐健身康复车颈椎腰椎被动和主动康复训练装置
CN109549815B (zh) *	2017-09-24	2024-04-09	湖北职业技术学院	一种娱乐健身康复车颈椎腰椎被动和主动康复训练装置

Legal Events

Date	Code	Title	Description
2002-10-24	FZDE	Dead

Publication	Publication Date	Title
US6273916B1 (en)	2001-08-14	Method and apparatus for strengthening vertebral bodies
Mathis et al.	2003	Percutaneous vertebroplasty: technical considerations
Coumans et al.	2003	Kyphoplasty for vertebral compression fractures: 1-year clinical outcomes from a prospective study
McGraw et al.	2002	Prospective evaluation of pain relief in 100 patients undergoing percutaneous vertebroplasty: results and follow-up
Murphy et al.	2001	Vertebroplasty: a simple solution to a difficult problem
Jang et al.	2005	Efficacy of percutaneous vertebroplasty combined with radiotherapy in osteolytic metastatic spinal tumors
Spivak et al.	2005	Percutaneous treatment of vertebral body pathology
Afzal et al.	2007	Percutaneous vertebroplasty for osteoporotic fractures
Kotil et al.	2012	Neurovascular complications of cervical pedicle screw fixation
Kim et al.	2014	Retrospective review of procedural parameters and outcomes of percutaneous vertebroplasty in 673 patients
Pan et al.	2020	Percutaneous vertebral augmentation in special Genant IV osteoporotic vertebral compression fractures
Liliang et al.	2005	Percutaneous vertebroplasty improves pain and physical functioning in elderly osteoporotic vertebral compression fracture patients
Huang et al.	2020	Treatment of typical enneking stage 3 thoracic aggressive vertebral hemangiomas with pain and neurologic deficits: results after at least 36 months of follow-up
Tang et al.	2025	Impact of intravertebral clefts sclerosis on percutaneous vertebroplasty efficacy in osteoporotic vertebral compression fractures
Lin et al.	2001	Percutaneous vertebroplasty in benign and malignant disease
Chen et al.	2004	Minimally invasive treatment of osteoporotic vertebral compression fracture
Gamal et al.	2023	Comparative study between vertebroplasty and kyphoplasty in management of osteoporotic vertebral body fractures
Zapalowicz et al.	2008	Balloon kyphoplasty for painful C-7 vertebral hemangioma: Case report
Sun et al.	2010	Percutaneous vertebroplasty for treatment of osteolytic metastases of the C2 vertebral body using anterolateral and posterolateral approach
Hee	2005	Percutaneous vertebroplasty: current concepts and local experience
Chen et al.	2015	Nonunion of osteoporotic vertebral compression fracture with a severe spinal stenosis treated in minimally invasive manner: a case report
CA2281335A1 (fr)	2001-03-02	Methode et dispositif pour renforcer et accroitre les elements vertebraux
Mathis et al.	2010	Percutaneous vertebroplasty
RU2432137C1 (ru)	2011-10-27	Способ перкутанной вертебропластики при травмах и заболеваниях позвоночника
Mehdizade et al.	2004	Percutaneous vertebroplasty through a transdiscal access route after lumbar transpedicular instrumentation